Cited by 1,596Cardiac Fibrosis and RemodelingCongenital heart defects researchLiver physiology and pathology

The DOI matches its Crossref record; 258 of the 261 references it cites were found in a registry or an index.

Cardiac Fibrosis: The Fibroblast Awakens

Open access

Travers, Joshua G., Kamal, Fadia A., Robbins, Jeffrey, Yutzey, Katherine E., Blaxall, Burns C.·2016·Circulation Research

DOI 10.1161/circresaha.115.306565PMC PMC4800485

Open this paper in CoChat — free account

Abstract

Myocardial fibrosis is a significant global health problem associated with nearly all forms of heart disease. Cardiac fibroblasts comprise an essential cell type in the heart that is responsible for the homeostasis of the extracellular matrix; however, upon injury, these cells transform to a myofibroblast phenotype and contribute to cardiac fibrosis. This remodeling involves pathological changes that include chamber dilation, cardiomyocyte hypertrophy and apoptosis, and ultimately leads to the progression to heart failure. Despite the critical importance of fibrosis in cardiovascular disease, our limited understanding of the cardiac fibroblast impedes the development of potential therapies that effectively target this cell type and its pathological contribution to disease progression. This review summarizes current knowledge regarding the origins and roles of fibroblasts, mediators and signaling pathways known to influence fibroblast function after myocardial injury, as well as novel therapeutic strategies under investigation to attenuate cardiac fibrosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/circresaha.115.306565

Cites

258 of 258 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

G protein-coupled receptor kinase-2 is a novel regulator of collagen synthesis in adult human cardiac fibroblasts.
D’Souza, K. M., Malhotra, R., Philip, J. L., Staron, M. L., Theccanat, T., Jeevanandam, V., & Akhter, S. A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.a111.218263 · Cited by 31
Retracted
Wound repair and regeneration
Gurtner, G. C., Werner, S., Barrandon, Y., & Longaker, M. T. (2008) · Nature · doi:10.1038/nature07039 · Cited by 6,542
Heart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., de Ferranti, S., Després, J.-P., Fullerton, H. J., Howard, V. J., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000152 · Cited by 5,797
Myofibroblasts and mechano-regulation of connective tissue remodelling
Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., & Brown, R. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm809 · Cited by 4,290
A perivascular origin for mesenchymal stem cells in multiple human organs
Crisan, M., Yap, S., Casteilla, L., Chen, C.-W., Corselli, M., Park, T. S., Andriolo, G., Sun, B., Zheng, B., Zhang, L., et al. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.07.003 · Cited by 3,991
Regulation of type I interferon responses
Ivashkiv, L. B., & Donlin, L. T. (2013) · Nature reviews. Immunology · doi:10.1038/nri3581 · Cited by 3,442
A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy
Molkentin, J. D., Lu, J., Antos, C. L., Markham, B. E., Richardson, J. A., Robbins, J. M., Grant, S. R., & Olson, E. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81573-1 · Cited by 2,566
Self-citation
Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors
Ieda, M., Fu, J.-D., Delgado-Olguin, P., Vedantham, V., Hayashi, Y., Bruneau, B. G., & Srivastava, D. (2010) · Cell · doi:10.1016/j.cell.2010.07.002 · Cited by 2,454
TGF-β signaling and the fibrotic response
Leask, A., & Abraham, D. J. (2004) · The FASEB Journal · doi:10.1096/fj.03-1273rev · Cited by 2,319
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., Chandraker, A. K., Yuan, X., Pu, W. T., Roberts, A. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1613 · Cited by 2,251

Flagged first, then by citations

Show all 261 references

3 of the 261 references couldn’t be matched to a known paper.

Sorted by citations

Items 701–800 of 999

Impact of stress, immunity, and signals from endocrine and nervous system on fascia
Barsotti, N., Chiera, M., Lanaro, D., & Fioranelli, M. (2020) · Frontiers in Bioscience-Elite · doi:10.2741/870 · Cited by 18
M2b macrophages protect against myocardial remodeling after ischemia/reperfusion injury by regulating kinase activation of platelet-derived growth factor receptor of cardiac fibroblast
Yuan, Y., Huang, S., Li, H., Li, W., Hou, J., Luo, L., Liu, Q., Wang, C., Song, Y., Lv, L., et al. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-2788 · Cited by 18
Long Non-Coding RNA 554 Promotes Cardiac Fibrosis via TGF-β1 Pathway in Mice Following Myocardial Infarction
Luo, B., He, Z., Huang, S., Wang, J., Han, D., Xue, H., Liu, P., Zeng, X., & Lu, D. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.585680 · Cited by 19
Lithium Reduces Migration and Collagen Synthesis Activity in Human Cardiac Fibroblasts by Inhibiting Store-Operated Ca2+ Entry
Chen, P., Chung, C., Lin, Y., Kao, Y., & Chen, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020842 · Cited by 20
Human Umbilical Cord Mesenchymal Stem Cells Alleviate Myocardial Endothelial-Mesenchymal Transition in a Rat Dilated Cardiomyopathy Model
Zhang, C., Zhou, Y., Lai, X., Zhou, G., Wang, H., Feng, X., Chen, Y., Wu, Y., Wang, T., & Ma, L. (2019) · Transplantation Proceedings · doi:10.1016/j.transproceed.2019.01.080 · Cited by 17
Adipose tissue–derived stromal cells’ conditioned medium modulates endothelial‐mesenchymal transition induced by IL‐1β/TGF‐β2 but does not restore endothelial function
Liguori, T. T. A., Liguori, G. R., Moreira, L. F. P., & Harmsen, M. C. (2019) · Cell Proliferation · doi:10.1111/cpr.12629 · Cited by 17
Parathyroid Hormone Induces Transition of Myofibroblasts in Arteriovenous Fistula and Increases Maturation Failure
Liu, C.-T., Hsu, S., Hsieh, H., Chen, C., Chen, C., Sue, Y., Lin, F., Shih, C., Shiu, Y.-T. E., & Huang, P. (2021) · Endocrinology · doi:10.1210/endocr/bqab044 · Cited by 17
Apilimod alters TGFβ signaling pathway and prevents cardiac fibrotic remodeling
Cinato, M., Guitou, L., Saidi, A., Timotin, A., Sperazza, E., Duparc, T., Zolov, S. N., Giridharan, S. S. P., Weisman, L. S., Martinez, L. O., et al. (2021) · Theranostics · doi:10.7150/thno.55821 · Cited by 17
G Protein-Coupled Receptor Kinase 2 as Novel Therapeutic Target in Fibrotic Diseases
Li, N., Shan, S., Li, X., Chen, T., Meng, Q., Zhang, S., Wang, Z., Zhang, L., Wei, W., & Sun, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.822345 · Cited by 17
Gpx3 and Egr1 Are Involved in Regulating the Differentiation Fate of Cardiac Fibroblasts under Pressure Overload
Li, G., Qin, Y., Cheng, Z., Cheng, X., Wang, R., Luo, X., Zhao, Y., Zhang, D., & Li, G. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3235250 · Cited by 17
Inhibition of the cardiac fibroblast-enriched histone methyltransferase Dot1L prevents cardiac fibrosis and cardiac dysfunction
Xu, J., Wang, J., Long, F., Zhong, W., Su, H., Su, Z., & Liu, X. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00877-5 · Cited by 20
REV-ERB is essential in cardiac fibroblasts homeostasis
Luo, X., Song, S., Qi, L., Tien, C., Li, H., Xu, W., Mathuram, T. L., Burris, T. P., Zhao, Y., Sun, Z., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.899628 · Cited by 17
Cardiomyocyte-fibroblast crosstalk in the postnatal heart
Calderon, M. U., Gonzalez, B. A., & Yutzey, K. E. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1163331 · Cited by 19
Self-citation
Biomimetic Electrospun Scaffold-Based In Vitro Model Resembling the Hallmarks of Human Myocardial Fibrotic Tissue
Ruocco, G., Zoso, A., Mortati, L., Carmagnola, I., & Chiono, V. (2023) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.3c00483 · Cited by 20
Decellularized heart extracellular matrix alleviates activation of hiPSC-derived cardiac fibroblasts
Kerr, C. M., Silver, S. E., Choi, Y. S., Floy, M. E., Bradshaw, A. D., Cho, S., Palecek, S. P., & Mei, Y. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.08.023 · Cited by 18
Imaging for the assessment of the arrhythmogenic potential of mitral valve prolapse
Esposito, A., Gatti, M., Trivieri, M., Agricola, E., Peretto, G., Gallone, G., Catapano, F., Pradella, S., Devesa, A., Bruno, E., et al. (2023) · European Radiology · doi:10.1007/s00330-023-10413-9 · Cited by 16
The Roles of Exosome-Derived microRNAs in Cardiac Fibrosis
Tang, X., Leng, M., Tang, W., Cai, Z., Yang, L., Wang, L., Zhang, Y., & Guo, J. (2024) · Molecules · doi:10.3390/molecules29061199 · Cited by 17
Daidzin and its de‐glycosylated constituent daidzein as a potential therapeutic for cardiovascular diseases: A review from bench to bed
Akhlaghipour, I., Shad, A. N., Askari, V. R., & Rahimi, V. B. (2024) · Phytotherapy Research · doi:10.1002/ptr.8261 · Cited by 17
Implantable Cardioverter Defibrillator and Resynchronization Therapy in Patients With Overt Chronic Kidney Disease
Varga, C. R., Cleland, J. G. F., Abraham, W. T., Lip, G. Y. H., Leyva, F., & Hatamizadeh, P. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.05.081 · Cited by 17
Sonodynamic Therapy Inhibits Fibrogenesis in Rat Cardiac Fibroblasts Induced by TGF-β1
Guo, Y., Dong, Z., Shi, Y., Wang, W., Wang, L., Sun, J., Sun, X., Tian, Z., Yao, J., Li, Z., et al. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000452571 · Cited by 17
MK5 haplodeficiency attenuates hypertrophy and preserves diastolic function during remodeling induced by chronic pressure overload in the mouse heart
Nawaito, S. A., Dingar, D. D., Sahadevan, P., Hussein, B., Sahmi, F., Shi, Y., Gillis, M., Gaestel, M., Tardif, J., & Allen, B. G. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00597.2016 · Cited by 17
Transient Receptor Potential Canonical 3 and Nuclear Factor of Activated T Cells C3 Signaling Pathway Critically Regulates Myocardial Fibrosis
Saliba, Y., Jebara, V. A., Hajal, J., Maroun, R. G., Chacar, S., Smayra, V., Abramowitz, J., Birnbaumer, L., & Farès, N. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7545 · Cited by 17
Cardiomyocyte calcineurin is required for the onset and progression of cardiac hypertrophy and fibrosis in adult mice
Martı́nez-Martı́nez, S., Lozano‐Vidal, N., López-Maderuelo, D., Jiménez‐Borreguero, L. J., Armesilla, A. L., & Redondo, J. M. (2018) · FEBS Journal · doi:10.1111/febs.14718 · Cited by 17
Identification of atrial fibrillation‐associated lncRNAs in atria from patients with rheumatic mitral valve disease
Wu, J., Han, D., Shi, R., Chen, M., Sun, J., Tian, H., & Yang, Y. (2019) · Microscopy Research and Technique · doi:10.1002/jemt.23261 · Cited by 17
Mechanism of Hydrogen Sulfide Preconditioning-Associated Protection Against Ischemia–Reperfusion Injury Differs in Diabetic Heart That Develops Myopathy
Ansari, M., & Kurian, G. A. (2019) · Cardiovascular Toxicology · doi:10.1007/s12012-019-09542-9 · Cited by 17
Erythropoietin protects propofol induced neuronal injury in developing rats by regulating TLR4/NF-κB signaling pathway abstract
Zhang, C., Wang, Y., Jin, J., & Li, K. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134517 · Cited by 17
‘PARP’ing fibrosis: repurposing poly (ADP ribose) polymerase (PARP) inhibitors
Rao, P. D., Sankrityayan, H., Srivastava, A., Kulkarni, Y. A., Mulay, S. R., & Gaikwad, A. B. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.04.019 · Cited by 17
Fingolimod Attenuates Lung Injury and Cardiac Dysfunction after Traumatic Brain Injury
Yu, Q., Gao, C., Zhao, X., Song, Y., Luo, H., An, S., Huang, J., Zhang, J., & Jiang, R. (2020) · Journal of Neurotrauma · doi:10.1089/neu.2019.6951 · Cited by 17
Clinicopathological Bird’s-Eye View of Left Atrial Myocardial Fibrosis in 121 Patients With Persistent Atrial Fibrillation
Callegari, S., Macchi, E., Monaco, R., Magnani, L., Tafuni, A., Croci, S., Nicastro, M., Garrapa, V., Banchini, A., Becchi, G., et al. (2020) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.119.007588 · Cited by 17
RNA interactions in right ventricular dysfunction induced type II cardiorenal syndrome
Chen, K., Huang, X., Xie, D., Shen, M., Lin, H., Zhu, Y., Ma, S., Zheng, C., Chen, L., Liu, Y., et al. (2021) · Aging · doi:10.18632/aging.202385 · Cited by 17
Isolation and culture of adult murine cardiac atrial and ventricular fibroblasts and myofibroblasts
Sahadevan, P., & Allen, B. G. (2021) · Methods · doi:10.1016/j.ymeth.2021.04.004 · Cited by 19
SGLT2 promotes cardiac fibrosis following myocardial infarction and is regulated by miR‑141
Li, G., Zhao, C., & Fang, S. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10147 · Cited by 17
P300/CBP-Associated Factor Activates Cardiac Fibroblasts by SMAD2 Acetylation
Lim, Y., Jeong, A., Kwon, D., Lee, Y.-U., Kim, Y., Ahn, Y., Kook, T., Park, W.-J., & Kook, H. Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189944 · Cited by 18
Dysregulation of nuclear factor erythroid 2-related factor 2 signaling and activation of fibrogenic pathways in hearts of high fat diet-fed rats
Elrashidy, R. A. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05360-3 · Cited by 17
Status and role of the ubiquitin–proteasome system in renal fibrosis
Chen, Y., Dai, R., Cheng, M., Wang, W., Liu, C., Cao, Z., Ge, Y., Wang, Y., & Zhang, L. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117210 · Cited by 19
Exploring radiation-induced fibrosis: biological mechanisms and new frontiers in research and therapeutics
Kreuder, L., Bissey, P.-A., Yip, K. W., & Liu, F. (2025) · International Journal of Radiation Biology · doi:10.1080/09553002.2025.2540353 · Cited by 16
Measurement of myocardial extracellular volume fraction in patients with heart failure with preserved ejection fraction using dual-energy computed tomography
Qi, R., Jiang, J.-S., Shao, J., Zhang, Q., Zheng, K., Xiao, J., Huang, S., & Gong, S. (2022) · European Radiology · doi:10.1007/s00330-021-08514-4 · Cited by 17
A New Hypothetical Concept in Metabolic Understanding of Cardiac Fibrosis: Glycolysis Combined with TGF-β and KLF5 Signaling
Methatham, T., Nagai, R., & Aizawa, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084302 · Cited by 17
An integral perspective of canonical cigarette and e-cigarette-related cardiovascular toxicity based on the adverse outcome pathway framework
Ding, R., Ren, X., Sun, Q., Sun, Z., & Duan, J. (2022) · Journal of Advanced Research · doi:10.1016/j.jare.2022.08.012 · Cited by 17
Immunosuppressants Tacrolimus and Sirolimus revert the cardiac antifibrotic properties of p38-MAPK inhibition in 3D-multicellular human iPSC-heart organoids
Tian, Y., Tsujisaka, Y., Li, V. Y., Tani, K., Lucena-Cacace, A., & Yoshida, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1001453 · Cited by 16
Activated fibroblasts in cardiac and cancer fibrosis: An overview of analogies and new potential therapeutic options
Nicolini, G., Balzan, S., & Forini, F. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121575 · Cited by 18
Engineering of MSCs sheet for the prevention of myocardial ischemia and for left ventricle remodeling
Chang, D., Yang, X., Fan, S., Fan, T., Zhang, M., & Ōno, M. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03322-7 · Cited by 16
Inhibition of miR-195-3p protects against cardiac dysfunction and fibrosis after myocardial infarction
Carvalho, A., Ji, Z., Zhang, R., Zuo, W., Qu, Y., Chen, X., Tao, Z., Ji, J., Yao, Y., & Ma, G. (2023) · International Journal of Cardiology · doi:10.1016/j.ijcard.2023.131128 · Cited by 16
Tissue kallikrein-related peptidase8 accentuates cardiac fibrosis after myocardial ischemia-reperfusion injury via regulation of cardiac fibroblasts
Song, J., Du, J., Tan, X. L., Li, Y., Yu, Q. C., Liu, W., Zhu, X., & Cong, B. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121973 · Cited by 16
A Review of Therapeutic Strategies against Cardiac Fibrosis: From Classical Pharmacology to Novel Molecular, Epigenetic, and Biotechnological Approaches
Floris, E., Cozzolino, C., Marconi, S., Tonicello, F., Picchio, V., Pagano, F., & Chimenti, I. (2023) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2408226 · Cited by 18
Cardiomyocyte intercellular signalling increases oxidative stress and reprograms the global‐ and phospho‐proteome of cardiac fibroblasts
Claridge, B., Rai, A., Lees, J. G., Fang, H., Lim, S. Y., & Greening, D. W. (2023) · Journal of Extracellular Biology · doi:10.1002/jex2.125 · Cited by 16
Exploring the role of pericardial miRNAs and exosomes in modulating cardiac fibrosis
Schoettler, F. I., Hassanabad, A. F., Jadli, A. S., Patel, V. B., & Fedak, P. W. M. (2024) · Cardiovascular Pathology · doi:10.1016/j.carpath.2024.107671 · Cited by 16
Multiphysics simulations reveal haemodynamic impacts of patient‐derived fibrosis‐related changes in left atrial tissue mechanics
Gonzalo, A., Augustin, C. M., Bifulco, S., Telle, Å., Chahine, Y., Kassar, A., Guerrero‐Hurtado, M., Durán, E., Martínez‐Legazpi, P., Flores, Ó., et al. (2024) · The Journal of Physiology · doi:10.1113/jp287011 · Cited by 18
Echocardiography in the Assessment of Heart Failure Patients
Dini, F. L., Cameli, M., Stefanini, A., Soliman-Aboumarie, H., Lisi, M., Lindqvist, P., & Henein, M. Y. (2024) · Diagnostics · doi:10.3390/diagnostics14232730 · Cited by 20
The Functional Role of Zinc Finger E Box-Binding Homeobox 2 (Zeb2) in Promoting Cardiac Fibroblast Activation
Jahan, F., Landry, N. M., Rattan, S. G., Dixon, I., & Wigle, J. T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103207 · Cited by 16
Functional Gene Module–Based Identification of Phillyrin as an Anticardiac Fibrosis Agent
Wang, L., Zhang, W., Lu, Z., Wang, B., Li, Y., Yang, J., Li, P., & Zhao, M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01077 · Cited by 16
Zerumbone prevents pressure overload-induced left ventricular systolic dysfunction by inhibiting cardiac hypertrophy and fibrosis
Sari, N., Katanasaka, Y., Sugiyama, Y., Sunagawa, Y., Miyazaki, Y., Funamoto, M., Shimizu, S., Shimizu, K., Murakami, A., Mori, K., et al. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153744 · Cited by 16
Crosstalk between Sodium–Glucose Cotransporter Inhibitors and Sodium–Hydrogen Exchanger 1 and 3 in Cardiometabolic Diseases
Al-Shamasi, A.-A., Elkaffash, R., Mohamed, M., Rayan, M., Al-Khater, D., Gadeau, A., Ahmed, R., Hasan, A., Eldassouki, H., Yalcin, H. C., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312677 · Cited by 18
The Role of c‐SKI in Regulation of TGFβ‐Induced Human Cardiac Fibroblast Proliferation and ECM Protein Expression
Wang, J., Guo, L., She, Z., Xu, X. H., Wang, J., Han, S., & He, W. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25935 · Cited by 16
Platelet Derived Growth Factor Alpha (PDGFRα) Induces the Activation of Cardiac Fibroblasts by Activating c-Kit
Wang, L., Yuan, Y., Yang, X. Q., Fan, T., Mei, B., Hou, J., Liang, M., Chen, G., & Wu, Z. (2017) · Medical Science Monitor · doi:10.12659/msm.906038 · Cited by 16
Unique mechanistic insights into the beneficial effects of angiotensin-(1-7) on the prevention of cardiac fibrosis: A metabolomic analysis of primary cardiac fibroblasts
Chen, Y., Fan, J., Cao, L., Han, T.-L., Zeng, M., Xu, Y., Ling, Z., & Yin, Y. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.03.006 · Cited by 16
Altered cardiac structure and function is related to seizure frequency in a rat model of chronic acquired temporal lobe epilepsy
Powell, K. L., Liu, Z., Curl, C. L., Raaijmakers, A. J. A., Sharma, P., Braine, E. L., Gomes, F. M. M., Sivathamboo, S., Macefield, V. G., Casillas-Espinosa, P. M., et al. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105505 · Cited by 16
The interplay of senescence and MMPs in myocardial infarction: implications for cardiac aging and therapeutics
Balaraman, A. K., Altamimi, A. S. A., Babu, M. A., Goyal, K., Padmapriya, G., Bansal, P., Rajotiya, S., Kumar, M., Rajput, P., Imran, M., et al. (2025) · Biogerontology · doi:10.1007/s10522-025-10190-6 · Cited by 16
Vascularized and Perfusable Human Heart‐on‐a‐Chip Model Recapitulates Aspects of Myocardial Ischemia and Enables Analysis of Nanomedicine Delivery
Kim, J., Zhang, X., Wang, R., Najer, A., Lau, Q. Y., Cammack-Najera, A., Kim, J. A., Kang, Y. K., Xie, R., Kim, H., et al. (2025) · Advanced Materials · doi:10.1002/adma.202418909 · Cited by 19
The extracellular matrix: structure, composition, biological functions, diseases, and therapeutic targets
Kamal, K. M., Ghazali, A. R., Selvarajah, G. T., Mutalib, N. A., Abu, N., Chua, E. W., & Masre, S. F. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00436-1 · Cited by 20
Role of sialidase Neu3 and ganglioside GM3 in cardiac fibroblasts activation
Ghiroldi, A., Piccoli, M., Creo, P., Cirillo, F., Rota, P., D’Imperio, S., Ciconte, G., Monasky, M. M., Micaglio, E., Garatti, A., et al. (2020) · Biochemical Journal · doi:10.1042/bcj20200360 · Cited by 16
Biomarkers of myocardial fibrosis and their genetic regulation in patients with heart failure
Борзалиевна, П. Т., & Кутихин, А. Г. (2020) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2020-3933 · Cited by 15
Toll-Like Receptor 3 in Cardiovascular Diseases
Zhuang, C., Chen, R., Zheng, Z., Lu, J., & Hong, C. (2022) · Heart Lung and Circulation · doi:10.1016/j.hlc.2022.02.012 · Cited by 15
MED1 Deficiency in Macrophages Aggravates Isoproterenol-Induced Cardiac Fibrosis in Mice
Fatima, M., Gao, J., Han, T., Ding, Y., Zhang, Y., Wen, E., Jia, L., Wang, R., Wang, W., Zhao, S., et al. (2022) · American Journal Of Pathology · doi:10.1016/j.ajpath.2022.03.013 · Cited by 15
MicroRNA‑146a attenuates isoproterenol‑induced cardiac fibrosis by inhibiting FGF2
Zhang, H., Wen, H., & Huang, Y. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11433 · Cited by 15
Small ubiquitin-related modifier (SUMO)ylation of SIRT1 mediates (-)-epicatechin inhibited- differentiation of cardiac fibroblasts into myofibroblasts
Luo, Y., Lu, J., Wang, Z., Wang, L., Wu, G., Guo, Y., & Dong, Z. (2022) · Pharmaceutical Biology · doi:10.1080/13880209.2022.2101672 · Cited by 15
miR‐409‐3p Regulated by GATA2 Promotes Cardiac Fibrosis through Targeting Gpd1
Wang, C., Yin, S., Wang, Q., Jiang, M., Li, S., Zhen, W., Duan, Y., & Gu, H. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/8922246 · Cited by 15
HuR-dependent expression of Wisp1 is necessary for TGF β -induced cardiac myofibroblast activity
Green, L. C., Slone, S., Anthony, S., Guarnieri, A., Parkins, S., Shearer, S. M., Nieman, M. L., Roy, S., Aubé, J., Wu, X., et al. (2022) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2022.10.007 · Cited by 15
Engineered human cardiac tissues for modeling heart diseases
Min, S., & Cho, S. (2022) · BMB Reports · doi:10.5483/bmbrep.2022-0185 · Cited by 16
COVID-19 HEART unveiling as atrial fibrillation: pathophysiology, management and future directions for research
Kanuri, S. H., Sirrkay, P. J., & Ulucay, A. S. (2023) · The Egyptian Heart Journal · doi:10.1186/s43044-023-00359-0 · Cited by 17
Isolation of Adult Mouse Cardiac Fibroblasts
Almazloum, A., & Khalil, H. (2023) · Current Protocols · doi:10.1002/cpz1.840 · Cited by 17
GPCRs and fibroblast heterogeneity in fibroblast‐associated diseases
Dwivedi, N. V., Datta, S., El‐Kersh, K., Sadikot, R. T., Ganti, A. K., Batra, S. K., & Jain, M. (2023) · The FASEB Journal · doi:10.1096/fj.202301091 · Cited by 16
Pseudomonas aeruginosa pulmonary infection results in S100A8/A9-dependent cardiac dysfunction
Kumar, N., Pestrak, M. J., Wu, Q., Ahumada, O. S., Dellos-Nolan, S., Saljoughian, N., Shukla, R. K., Mitchem, C. F., Nagareddy, P. R., Ganesan, L. P., et al. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011573 · Cited by 15
Mitophagy deficiency activates stimulator of interferon genes activation and aggravates pathogenetic cardiac remodeling
Zhou, G., Wang, X., Guo, M., Qu, C., Gao, L., Yu, J., Li, Y., Luo, S., Shi, Q., & Guo, Y. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.08.003 · Cited by 15
Cardioprotective Effects of the GRK2 Inhibitor Paroxetine on Isoproterenol-Induced Cardiac Remodeling by Modulating NF-κB Mediated Prohypertrophic and Profibrotic Gene Expression
Alonazi, A. S., Dayel, A. F. B., Albuaijan, D. A., Osfur, A. S. B., Hakami, F. M., Alzayed, S. S., Almotairi, A. R., Khan, M. R., Alharbi, H. M., Ali, R., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417270 · Cited by 15
lncRNA TUG1 as Potential Novel Biomarker for Prognosis of Cardiovascular Diseases
Haybar, H., Sadati, N. S., Purrahman, D., Mahmoudian‐Sani, M., & Saki, N. (2023) · Epigenomics · doi:10.2217/epi-2023-0242 · Cited by 15
Targeting cardiac fibrosis with Chimeric Antigen Receptor-Engineered Cells
Zhang, Q., Dai, J., Liu, T., Rao, W., Li, D., Gu, Z., Huang, L., Wang, J., & Hou, X. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05134-6 · Cited by 15
Poly(ADP‐ribose) polymerase 1 induces cardiac fibrosis by mediating mammalian target of rapamycin activity
Sun, S., Hu, Y., Zheng, Q., Guo, Z., Sun, D., Chen, S., Zhang, Y., Liu, P., Lü, J., & Jiang, J. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26649 · Cited by 15
Machine Learning-Based Segmentation of Left Ventricular Myocardial Fibrosis from Magnetic Resonance Imaging
Zabihollahy, F., Rajan, S., & Ukwatta, E. (2020) · Current Cardiology Reports · doi:10.1007/s11886-020-01321-1 · Cited by 17
Myocardial Fibrosis in a 3D Model: Effect of Texture on Wave Propagation
Dokuchaev, A., Panfilov, A. V., & Solovyova, O. E. (2020) · Mathematics · doi:10.3390/math8081352 · Cited by 15
Signalling pathways linking cysteine cathepsins to adverse cardiac remodelling
O'Toole, D., Zaeri, A. A. I., Nicklin, S. A., French, A. T., Loughrey, C. M., & Martin, T. P. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109770 · Cited by 16
Macrophage p47phox regulates pressure overload-induced left ventricular remodeling by modulating IL-4/STAT6/PPARγ signaling
Reddy, S. S., Agarwal, H., Jaiswal, A., Jagavelu, K., Dikshit, M., & Barthwal, M. K. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.03.007 · Cited by 15
CIHH protects the heart against left ventricular remodelling and myocardial fibrosis by balancing the renin-angiotensin system in SHR
Yu, B., Chen, H., Guo, X., Hua, H., Guan, Y., Cui, F., Tian, Y., Zhang, H.-X., Zhang, X., Zhang, Y., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119540 · Cited by 15
From dissection of fibrotic pathways to assessment of drug interactions to reduce cardiac fibrosis and heart failure
Garoffolo, G., & Pesce, M. (2021) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2021.100036 · Cited by 15
P16ink4a overexpression ameliorates cardiac remodeling of mouse following myocardial infarction via CDK4/pRb pathway
Shi, J., Sun, J., Liu, L., Shan, T., Meng, H., Yang, T., Wang, S., Wei, T., Chen, B., Ma, Y., et al. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.01.077 · Cited by 15
Associations between Left Ventricular Cavity Size and Cardiac Function and Overload Determined by Natriuretic Peptide Levels and a Covariance Structure Analysis
Yoshida, J., Kawai, M., Minai, K., Ogawa, K., Ogawa, T., & Yoshimura, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-02247-5 · Cited by 15
THE MECHANISMS OF HEART FAILURE DEVELOPMENT IN OBESITY
Гриценко, О. В., Chumakova, G. A., Shevlyakov, I. V., & Trubina, E. V. (2018) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2018-5-81-86 · Cited by 15
Pharmacological Inhibition of Soluble Epoxide Hydrolase Ameliorates Chronic Ethanol‐Induced Cardiac Fibrosis by Restoring Autophagic Flux
Zhou, C., Huang, J., Li, Q., Zhan, C., He, Y., Liu, J., Zheng, W., & Wang, D. W. (2018) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13847 · Cited by 15
Erratum: Aucubin Protects against TGFβ1-Induced Cardiac Fibroblasts Activation by Mediating the AMPKα/mTOR Signaling Pathway
Xiao, Y., Chang, W., Wu, Q., Jiang, X., Duan, M., Jin, Y., & Tang, Q. (2017) · Planta Medica · doi:10.1055/s-0043-122577 · Cited by 15
TGF-β Inhibitor CILP as a Novel Biomarker for Cardiac Fibrosis
Groß, S., & Thum, T. (2020) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2020.03.013 · Cited by 17
Cellular senescence as a key player in chronic heart failure pathogenesis: Unraveling mechanisms and therapeutic opportunities
Zhao, S., Zhang, Y., Zhao, Y. R., & Lu, X. (2025) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2025.02.002 · Cited by 15
Functions of the Muscleblind-like protein family and their role in disease
Zhou, H., Xu, J., & Pan, L. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02102-5 · Cited by 14
The theatrics of collagens in the myocardium: the supreme architect of the fibrotic heart
Chakraborty, S., Dutta, A., Roy, A., Joshi, A., & Basak, T. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.01043.2024 · Cited by 23
cGAS–STING signaling pathway as a therapeutic target in human diseases
Xiao, Y., Ma, Y., Zhao, J., Zhang, X., Gan, C., Gao, J., & Huang, Z. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003904 · Cited by 15
Serum N-Acetylneuraminic Acid Is Associated with Atrial Fibrillation and Left Atrial Enlargement
Hu, W. G., Xie, J., Zhu, T., Meng, G., Wang, M., Zhou, Z., Guo, F., Chen, H., Wang, Z., Wang, S., et al. (2020) · Cardiology Research and Practice · doi:10.1155/2020/1358098 · Cited by 14
Role of the Renin–Angiotensin–Aldosterone System in Dystrophin-Deficient Cardiomyopathy
Rodríguez‐González, M., Lubián-Gutiérrez, M., Cascales-Poyatos, H. M., Pérez-Reviriego, Á. A., & Castellano‐Martínez, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010356 · Cited by 14
Micronized Acellular Matrix Biomaterial Leverages Eosinophils for Postinfarct Cardiac Repair
Vasanthan, V., Hassanabad, A. F., Belke, D. D., Teng, G., Isidoro, C. A., Dutta, D., Turnbull, J., Deniset, J., & Fedak, P. W. M. (2023) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2023.01.012 · Cited by 14
Cavin-2 Promotes Fibroblast-to-Myofibroblast Trans-Differentiation and Aggravates Cardiac Fibrosis
Higuchi, Y., Ogata, T., Nakanishi, N., Nishi, M., Tsuji, Y., Tomita, S., Conway, S. J., & Matoba, S. (2023) · ESC Heart Failure · doi:10.1002/ehf2.14571 · Cited by 14
An eNAMPT-neutralizing mAb reduces post-infarct myocardial fibrosis and left ventricular dysfunction
Liu, Z., Sammani, S., Barber, C. J., Kempf, C. L., Li, F., Yang, Z., Bermudez, R. T., Camp, S. M., Hernon, V. R., Furenlid, L. R., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.116103 · Cited by 15
Overview of Injectable Hydrogels for the Treatment of Myocardial Infarction
Yi, B., Xu, Y., Wang, X., Wang, G., Li, S., Xu, R., Liu, X., & Zhou, Q. (2024) · Cardiovascular Innovations and Applications · doi:10.15212/cvia.2024.0019 · Cited by 14

Authors: Travers, J. G., Kamal, F. A., Robbins, J., Yutzey, K. E., & Blaxall, B. C.
Affiliations: Cincinnati Children's Hospital Medical Center (US)
ORCID: Travers, Joshua G.
Kamal, Fadia A.
Robbins, Jeffrey
Yutzey, Katherine E.
Venue: Circulation Research
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2016-03-18
Volume: 118
Issue: 6
Pages: 1021-1040
ISSN: 0009-7330 (ISSN-L)
1524-4571
DOI: 10.1161/circresaha.115.306565
PMC: PMC4800485
OpenAlex: W2299099463
Cited by: 1,596
References: 261
Citations by year: 2026: 156 · 2025: 175 · 2024: 184 · 2023: 182 · 2022: 156 · 2021: 211 · 2020: 163 · 2019: 143 · 2018: 98 · 2017: 95 · 2016: 30
FWCI: 21.30
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Circulation Research (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Heart, Lung, and Blood Institute (P01HL069779, R01HL129772, R01HL091475, R01HL134312, R01HL132551, R01HL133695, U54HL119810)
National Institute of General Medical Sciences (R01GM097347)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Keywords: myocardial fibrosis, cardiac fibroblasts, myofibroblast differentiation, extracellular matrix homeostasis, myocardial injury, cardiac remodeling, cardiomyocyte hypertrophy, cardiomyocyte apoptosis, heart failure, signaling pathways, treatment options
MeSH terms: Animals, Fibroblasts, Fibrosis, Heart Failure, Humans, Cardiomyopathies, Inflammation Mediators, Myofibroblasts

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cardiac Fibrosis: The Fibroblast Awakens

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks